Technological Advancements in Injectable Devices Drive Demand for Syringes, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a comprehensive global report on Syringes (Disposable & Reusable) markets. Global demand for syringes (disposable & reusable) is projected to exceed US$16 billion by 2020, driven by rising healthcare needs of an aging population, increasing incidence of chronic diseases requiring intravenous administration of drugs, and strong emphasis on patient and healthcare worker safety.

Syringes (Disposable & Reusable): A Global Strategic Business Report

Follow us on LinkedIn – Syringes are widely used in hospitals, immunization programs, and intravenous drug administration. Rising incidence of chronic diseases continues to drive the need for injectable devices, hence generating demand for syringes. Syringes comprise disposable and reusable syringes, with disposables syringes capturing a significantly large share of the market amidst growing emphasis on safety and concerns over cross-contamination. The global market is dynamic and continues to be influenced by increasing use of biological drugs and government regulations focusing on patient and healthcare worker safety. The development of advanced drug delivery systems is expected to bolster demand for safety syringes and needle-free injections. Adoption of regulations aimed at ensuring patient safety is also helping drive growth in the market. Use of auto-disposable syringes is mandatory in several countries with several other countries expected to follow suit over the next few years.

Hypodermic syringes represents the largest product market supported by the increasing adoption of prefilled syringes. Prefilled syringes have emerged as one of the most preferred delivery devices for injectable drugs due to benefits such as, ease-of-use, reduced risk of cross-contamination, and elimination of drug counterfeiting and dosing error commonly associated with ampoules or vials. These syringes are preferred for the treatment of chronic diseases, which often requires patients to self-administer drugs on a frequent basis. The injectable drug delivery market is witnessing a paradigm shift towards self-injection devices as a result of the do-It-yourself health care trend, as empowered patients seek to remain in control of their health. Diabetes management offers lucrative opportunities for “Do-It-Yourself Injectables” market. Self-administration of insulin shots is driving demand for syringes with intuitive, ergonomic designs that prevent accidental needle stick injury and enable safe self-injection.

As stated by the new market research report on Syringes (Disposable & Reusable), the United States represents the largest market worldwide supported by the growing number of insulin-dependent diabetics in the country. Asia-Pacific is forecast to witness the fastest growth with a CAGR of 11% over the analysis period led by rising healthcare spends, improving healthcare infrastructure facilities, increasing use of injectable drugs, and rising demand from immunization programs.

Major players covered in the report include Abbott Laboratories Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Covidien, C. R. Bard Inc., Kawamoto Corporation, Medline Industries Inc., Smiths Medical, and Terumo Corporation among others.

The research report titled "Syringes (Disposable & Reusable): A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, mergers, acquisitions and other strategic industry activities. The report provides market estimates and projections for geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Middle East and Latin America (Brazil and Rest of Latin America). Product segments analyzed include Anesthesia Syringes, Angiographic Syringes, Blood Gas Syringes, Catheter Syringes, Dental Syringes, Ear Syringes, Hypodermic Syringes (Prefilled and Others), Insulin Syringes, Intraligamentary Syringes, and Irrigating Syringes.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Raghu Gopal
Global Industry Analysts Inc
+1 408-528-9966
Email >
Visit website